These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21609375)

  • 21. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.
    Salvalaggio PR; Felga GE; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2449-51. PubMed ID: 23026617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation.
    Nemes B; Gámán G; Polak WG; Gelley F; Hara T; Ono S; Baimakhanov Z; Piros L; Eguchi S
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):841-59. PubMed ID: 26831547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival.
    Frongillo F; Avolio AW; Nure E; Mulè A; Pepe G; Magalini SC; Agnes S
    Transplant Proc; 2009 May; 41(4):1268-72. PubMed ID: 19460535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of ischemia/reperfusion injury in time-zero biopsies predicts liver allograft outcomes.
    Ali JM; Davies SE; Brais RJ; Randle LV; Klinck JR; Allison ME; Chen Y; Pasea L; Harper SF; Pettigrew GJ
    Liver Transpl; 2015 Apr; 21(4):487-99. PubMed ID: 25545865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients.
    Ito T; Naini BV; Markovic D; Aziz A; Younan S; Lu M; Hirao H; Kadono K; Kojima H; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
    Am J Transplant; 2021 Feb; 21(2):614-625. PubMed ID: 32713098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
    de Graaf EL; Kench J; Dilworth P; Shackel NA; Strasser SI; Joseph D; Pleass H; Crawford M; McCaughan GW; Verran DJ
    J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.
    Karp SJ; Johnson S; Evenson A; Curry MP; Manning D; Malik R; Lake-Bakaar G; Lai M; Hanto D
    HPB (Oxford); 2011 Jun; 13(6):411-6. PubMed ID: 21609374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
    Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
    Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postreperfusion hyperkalemia in liver transplantation using donation after cardiac death grafts with pathological changes.
    Zhang WJ; Xia WL; Pan HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):487-492. PubMed ID: 27733317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation.
    Andert A; Ulmer TF; Schöning W; Kroy D; Hein M; Alizai PH; Heidenhain C; Neumann U; Schmeding M
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):617-623. PubMed ID: 29291781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary non-function is frequently associated with fatty liver allografts and high mortality after re-transplantation.
    Kulik U; Lehner F; Klempnauer J; Borlak J
    Liver Int; 2017 Aug; 37(8):1219-1228. PubMed ID: 28267886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors of early liver dysfunction after liver transplantation using grafts from donation after citizen death donors.
    He YB; Sun JS; Wang ZP; Yao G; Bai L; Li T; Zhao JM
    Transpl Immunol; 2022 Apr; 71():101525. PubMed ID: 34990790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric Donor to Adult Recipients in Donation After Cardiac Death Liver Transplantation: A Single-Center Experience.
    Lan C; Song JL; Yan LN; Yang JY; Wen TF; Li B; Xu MQ
    Transplant Proc; 2017; 49(6):1383-1387. PubMed ID: 28736011
    [TBL] [Abstract][Full Text] [Related]  

  • 34.  Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts.
    Taner CB; Bulatao IG; Arasi LC; Perry DK; Willingham DL; Sibulesky L; Rosser BG; Canabal JM; Nguyen JH; Kramer DJ
    Ann Hepatol; 2012; 11(5):679-85. PubMed ID: 22947529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation.
    Zhu Z; Tang Y; Huang S; Zhao Q; Schroder PM; Zhang Z; Zhang Y; Sun C; Wang L; Ju W; Wang D; Guo Z; He X
    Clin Transplant; 2018 Dec; 32(12):e13438. PubMed ID: 30383902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of graft steatosis on liver function and organ survival after liver transplantation.
    Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F
    Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longterm results of liver transplantation from donation after circulatory death.
    Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
    Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the Predictive Ability for Graft Loss and Mortality of Two Criteria for Early Allograft Dysfunction After Liver Transplantation.
    Brea-Gómez E; Villar-Quintana R; Plata-Illescas C; Zambudio-Carroll N; Lopez-Garrido MA; Nogueras-Lopez F; Muffak-Granero K; Becerra-Massare A; Villegas-Herrera MT; Segura Jiménez I; Muñoz Pérez N; Villar-Del-Moral JM
    Transplant Proc; 2018 Mar; 50(2):605-609. PubMed ID: 29579865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study.
    D'Errico A; Riefolo M; Serenari M; De Pace V; Santandrea G; Monica M; de Cillia C; Ravaioli M; Cescon M; Vasuri F;
    Dig Liver Dis; 2020 Feb; 52(2):185-189. PubMed ID: 31155489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.